Doripenem: A New Addition to the Carbapenem Class of Antimicrobials

Author(s): Jason J. Schafer, Debra A. Goff, Julie E. Mangino

Journal Name: Recent Patents on Anti-Infective Drug Discovery

Volume 4 , Issue 1 , 2009

Become EABM
Become Reviewer

Abstract:

Doripenem (DPM) is the newest antimicrobial in the carbapenem class. It is a broad spectrum agent with activity against gram-positive, gram-negative and anaerobic bacteria. in vitro Susceptibility testing has demonstrated potent activity for many drug resistant gram-negative pathogens including some that are resistant to imipenem and meropenem. It appears to be less likely to induce resistance for certain pathogens compared to the other carbapenems. The purpose of this review is to introduce DPM and describe its potential role in managing infections due to multi-drug resistant gram-negative bacteria. This article also reviews recent patents related to the carbapenem class of antimicrobials.

Keywords: Doripenem, carbapenem, pseudomonas, multi-drug resistant, pharmacodynamics

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 4
ISSUE: 1
Year: 2009
Page: [18 - 28]
Pages: 11
DOI: 10.2174/157489109787236283

Article Metrics

PDF: 12